331 related articles for article (PubMed ID: 16643902)
21. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
[TBL] [Abstract][Full Text] [Related]
22. Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates.
Kershaw NJ; Laktyushin A; Nicola NA; Babon JJ
Growth Factors; 2014 Feb; 32(1):1-10. PubMed ID: 24438103
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.
Zadjali F; Pike AC; Vesterlund M; Sun J; Wu C; Li SS; Rönnstrand L; Knapp S; Bullock AN; Flores-Morales A
J Biol Chem; 2011 Jan; 286(1):480-90. PubMed ID: 21030588
[TBL] [Abstract][Full Text] [Related]
24. Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.
Wang T; Luo S; Qin H; Xia Y
Free Radic Biol Med; 2018 Mar; 117():90-98. PubMed ID: 29367003
[TBL] [Abstract][Full Text] [Related]
25. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
[TBL] [Abstract][Full Text] [Related]
26. The suppressors of cytokine signalling E3 ligases behave as tumour suppressors.
Elliott J; Hookham MB; Johnston JA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):464-8. PubMed ID: 18481982
[TBL] [Abstract][Full Text] [Related]
27. ASB2α, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domain.
Razinia Z; Baldassarre M; Cantelli G; Calderwood DA
J Biol Chem; 2013 Nov; 288(44):32093-105. PubMed ID: 24052262
[TBL] [Abstract][Full Text] [Related]
28. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2.
Yamanaka K; Ishikawa H; Megumi Y; Tokunaga F; Kanie M; Rouault TA; Morishima I; Minato N; Ishimori K; Iwai K
Nat Cell Biol; 2003 Apr; 5(4):336-40. PubMed ID: 12629548
[TBL] [Abstract][Full Text] [Related]
29. Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3.
Williams JJ; Palmer TM
Biochem Soc Trans; 2012 Feb; 40(1):215-8. PubMed ID: 22260693
[TBL] [Abstract][Full Text] [Related]
30. The many faces of the SOCS box.
Piessevaux J; Lavens D; Peelman F; Tavernier J
Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic insights into the enzymatic activity of E3 ligase HOIL-1L and its regulation by the linear ubiquitin chain binding.
Xu X; Wang Y; Zhang Y; Wang Y; Yin Y; Peng C; Gong X; Li M; Zhang Y; Zhang M; Tang Y; Zhou X; Liu H; Pan L
Sci Adv; 2023 Oct; 9(41):eadi4599. PubMed ID: 37831767
[TBL] [Abstract][Full Text] [Related]
32. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
Yang L; Wang N; Tang Y; Cao X; Wan M
Hum Mutat; 2006 Sep; 27(9):897-905. PubMed ID: 16865698
[TBL] [Abstract][Full Text] [Related]
33. Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3.
Kazi JU; Sun J; Phung B; Zadjali F; Flores-Morales A; Rönnstrand L
J Biol Chem; 2012 Oct; 287(43):36509-17. PubMed ID: 22952242
[TBL] [Abstract][Full Text] [Related]
34. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
35. SIAH-1 interacts with mammalian polyhomeotic homologues HPH2 and affects its stability via the ubiquitin-proteasome pathway.
Wu H; Lin Y; Shi Y; Qian W; Tian Z; Yu Y; Huo K
Biochem Biophys Res Commun; 2010 Jul; 397(3):391-6. PubMed ID: 20471960
[TBL] [Abstract][Full Text] [Related]
36. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.
Rui L; Yuan M; Frantz D; Shoelson S; White MF
J Biol Chem; 2002 Nov; 277(44):42394-8. PubMed ID: 12228220
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.
Belova L; Sharma S; Brickley DR; Nicolarsen JR; Patterson C; Conzen SD
Biochem J; 2006 Dec; 400(2):235-44. PubMed ID: 16895519
[TBL] [Abstract][Full Text] [Related]
38. SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.
Ungureanu D; Silvennoinen O
Sci STKE; 2005 Oct; 2005(304):pe49. PubMed ID: 16204702
[TBL] [Abstract][Full Text] [Related]
39. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.
Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI
Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570
[TBL] [Abstract][Full Text] [Related]
40. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.
Furukawa M; Xiong Y
Mol Cell Biol; 2005 Jan; 25(1):162-71. PubMed ID: 15601839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
